EUVIMEDEUVIMED entdecken
Crossref

Pantothenate metabolic alterations in PROS1 mutation carriers and the antithrombotic effects of pantethine

Mao Xia, Jie Hu, Guanghao Song, Haixuan Sun, Jie Dong, Aiqin Jiang, Huiying Li

Thrombosis and Haemostasis · 10.11.2026

DOI: 10.1055/a-2999-4020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 10.11.2026. Verfasst von Mao Xia und 6 weiteren Autor:innen. Beteiligte Einrichtung: Nantong University Affiliated Hospital, Department of Laboratory Medicine, Jiangsu, China, Nantong. Gefördert von: Jiangsu Provincial Research Hospital.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients carrying PROS1 mutations are at increased risk of venous thromboembolism (VTE). However, metabolic alterations linked to PROS1 mutations and their thrombotic contribution remain unclear.

Objectives

This study aimed to identify metabolic changes in PROS1‑mutation patients through integrated multi‑omics analyses, and to investigate the role of pantothenate derivatives in thrombosis using in vivo and in vitro models.

Methods

Serum metabolomics, siRNA‑mediated PROS1 knockdown in THLE‑2 cells, murine thrombosis models, and endothelial cell functional assays were employed.

Results

Patients with PROS1 mutations exhibited significantly reduced serum levels of pantothenate derivatives, particularly pantetheine. siRNA‑mediated PROS1 knockdown in THLE‑2 cells recapitulated this metabolic disturbance. In vivo, pantethine supplementation attenuated thrombus formation and platelet activation in murine models, accompanied by reduced serum levels of vWF and ICAM‑1, and increased TFPI. In vitro, pantethine pretreatment suppressed NF‑κB phosphorylation and reduced endothelial reactive oxygen species, counteracting IL‑1β‑induced procoagulant phenotype, leading to downregulation of vWF and ICAM‑1 and upregulation of TFPI and THBD. Furthermore, pantethine‑conditioned endothelial cells reduced responsiveness of co‑incubated platelets, including attenuated spreading, aggregation, and activation. These findings associate PROS1 mutation‑driven metabolic alterations with thrombotic risk, and suggest a metabolic‑endothelial‑platelet mode of interaction.

Conclusions

This study demonstrates that patients with PROS1 mutations exhibit reduced circulating pantothenate derivatives, and that pantethine attenuates murine thrombosis and modulates endothelial and platelet function in vitro. These findings identify a metabolic‑endothelial‑platelet association in Protein S deficiency. Whether PROS1 mutations directly cause pantothenate metabolic disturbance, and whether this disturbance mediates thrombosis, require testing in PROS1‑deficient in vivo models.

Autor:innen und Institutionen

  • Nantong University Affiliated Hospital, Department of Laboratory Medicine, Jiangsu, China, Nantong.
  • Nantong University, Department of Laboratory Medicine, Jiangsu, China, Nantong.
  • Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital Department of Laboratory Medicine, Department of Laboratory Medicine, Jiangsu, China, Nanjing.
  • Chinese Academy of Sciences Suzhou Institute of Biomedical Engineering and Technology, Suzhou Institute of Biomedical Engineering and Technology, Jiangsu, China, Suzhou.
  • Nantong University, Department of Pathogen Biology, Jiangsu, China, Nantong.
  • Nanjing University, Jiangsu Key Laboratory of Molecular Medicine, Jiangsu, China, Nanjing.

Förderung

  • Jiangsu Provincial Research Hospital

Zitieren

APA

Xia, M., Hu, J., Song, G., Sun, H., Dong, J., Jiang, A., & Li, H. (2026). Pantothenate metabolic alterations in PROS1 mutation carriers and the antithrombotic effects of pantethine. Thrombosis and Haemostasis. https://doi.org/10.1055/a-2999-4020

Vancouver

Xia M, Hu J, Song G, Sun H, Dong J, Jiang A, et al. Pantothenate metabolic alterations in PROS1 mutation carriers and the antithrombotic effects of pantethine. Thrombosis and Haemostasis. 2026. doi:10.1055/a-2999-4020

BibTeX
@article{Xia2026,
  author = {Xia, Mao and Hu, Jie and Song, Guanghao and Sun, Haixuan and Dong, Jie and Jiang, Aiqin and Li, Huiying},
  title = {Pantothenate metabolic alterations in PROS1 mutation carriers and the antithrombotic effects of pantethine},
  journal = {Thrombosis and Haemostasis},
  year = {2026},
  doi = {10.1055/a-2999-4020}
}
Kostenlos starten →